BackTonix Pharmaceuticals Holding Overview

Tonix Pharmaceuticals Holding Receivables

Latest receivables for TNXP: $8.8M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$8.82M
166.30% YoYΔ $5.51M vs prior year quarter

Peer average

Loading

Tonix Pharmaceuticals Holding Receivables History

Loading

Tonix Pharmaceuticals Holding vs. peers: Receivables Comparison

Loading

Tonix Pharmaceuticals Holding Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Tonix Pharmaceuticals Holding (TNXP) FAQ

As of the most recent data (March 2026), TNXP shows a receivables of $8.8M. That compares with $3.3M in the prior-year period — up 166.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TNXP's receivables is now $8.8M (was $3.3M) — a 166.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Tonix Pharmaceuticals Holding is outperforming or lagging.

Tracking TNXP's receivables over time shows whether Tonix Pharmaceuticals Holding is scaling, shrinking, or reshaping that part of the business. The current reading is $8.8M That compares with $3.3M in the prior-year period — up 166.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Tonix Pharmaceuticals Holding's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $8.8M) with ownership activity and broader fundamentals.

Tonix Pharmaceuticals Holding's receivables is $8.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.